Wegovy 1 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FV3Q2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,518
Award facts
- Contract value 100% obligated
- $19,517.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,517.68 delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Wegovy 1 mg/0.5 mL pens (0.5 mL units). This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 27, 2025. Wegovy is a brand-name pharmaceutical product primarily used for weight management in patients with obesity or overweight conditions and related comorbidities.
As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains through competitively awarded agreements. This delivery order exemplifies the routine pharmaceutical procurement conducted under the DLA's Pharmaceutical Prime Vendor Global Program, which supports Defense Health Agency medical supply requirements and other government healthcare systems worldwide. The expedited three-day delivery timeline reflects the mission-critical nature of pharmaceutical supply chain management within the Department of Defense medical system.
Quick answers
Who was awarded contract SPE2DB26FV3Q2?
SPE2DB26FV3Q2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FV3Q2 worth?
The government has obligated $19,518 on SPE2DB26FV3Q2.
Is contract SPE2DB26FV3Q2 an order under another contract?
Yes. SPE2DB26FV3Q2 is a delivery order under SPE2DB20D3104, an indefinite delivery contract.
Was contract SPE2DB26FV3Q2 competed?
The extent of competition for SPE2DB26FV3Q2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award